Literature DB >> 6725560

L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia.

C R Roe, D S Millington, D A Maltby, T P Bohan, C L Hoppel.   

Abstract

Treatment with L-carnitine greatly enhanced the formation and excretion of short-chain acylcarnitines in three patients with propionic acidemia and in three normal controls. The use of fast atom bombardment mass spectrometry and linked scanning at constant magnetic (B) to electric (E) field ratio identified the acylcarnitine as propionylcarnitine in patients with propionic acidemia. The normal children excreted mostly acetylcarnitine. Propionic acidemia and other organic acidurias are characterized by the intramitochondrial accumulation of short-chain acyl-Coenzyme A (CoA) compounds. The substrate specificity of the carnitine acetyltransferase enzyme and its steady state nature appears to facilitate elimination of propionyl groups while restoring the acyl-CoA:free CoA ratio in the mitochondrion. We suggest that L-carnitine may be a useful therapeutic approach for elimination of toxic acyl CoA compounds in several of these disorders.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6725560      PMCID: PMC437091          DOI: 10.1172/JCI111387

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Comparison of the carnitine acyltransferase activites from rat liver peroxisomes and microsomes.

Authors:  M A Markwell; N E Tolbert; L L Bieber
Journal:  Arch Biochem Biophys       Date:  1976-10       Impact factor: 4.013

2.  Propionylcarnitine. Physiological variations in vivo.

Authors:  T Bohmer; J Bremer
Journal:  Biochim Biophys Acta       Date:  1968-05-01

3.  Hypocarnitinemia in disorders of organic acid metabolism.

Authors:  R J Allen; D B Hansch; H L Wu
Journal:  Lancet       Date:  1982-08-28       Impact factor: 79.321

4.  L-carnitine therapy in propionicacidaemia.

Authors:  C R Roe; T P Bohan
Journal:  Lancet       Date:  1982-06-19       Impact factor: 79.321

5.  Carnitine metabolism in the fasting rat.

Authors:  E P Brass; C L Hoppel
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

6.  Relationship between acid-soluble carnitine and coenzyme A pools in vivo.

Authors:  E P Brass; C L Hoppel
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

7.  Application of high resolution fast atom bombardment and constant B/E ratio linked scanning to the identification and analysis of acylcarnitines in metabolic disease.

Authors:  D S Millington; C R Roe; D A Maltby
Journal:  Biomed Mass Spectrom       Date:  1984-05

8.  Glycine cleavage system in ketotic hyperglycinemia: a reduction of H-protein activity.

Authors:  K Hayasaka; K Narisawa; T Satoh; H Tateda; K Metoki; K Tada; K Hiraga; T Aoki; T Kawakami; H Akamatsu; N Matsuo
Journal:  Pediatr Res       Date:  1982-01       Impact factor: 3.756

9.  Propionate inhibition of succinate:CoA ligase (GDP) and the citric acid cycle in mitochondria.

Authors:  D A Stumpf; J McAfee; J K Parks; L Eguren
Journal:  Pediatr Res       Date:  1980-10       Impact factor: 3.756

10.  Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia.

Authors:  F X Coude; L Sweetman; W L Nyhan
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

View more
  36 in total

Review 1.  Acute management of propionic acidemia.

Authors:  Kimberly A Chapman; Andrea Gropman; Erin MacLeod; Kathy Stagni; Marshall L Summar; Keiko Ueda; Nicholas Ah Mew; Jill Franks; Eddie Island; Dietrich Matern; Loren Pena; Brittany Smith; V Reid Sutton; Tiina Urv; Charles Venditti; Anupam Chakrapani
Journal:  Mol Genet Metab       Date:  2011-09-24       Impact factor: 4.797

2.  Direct identification of propionylcarnitine in propionic acidaemia: biochemical and clinical results of oral carnitine supplementation.

Authors:  M Duran; D Ketting; T E Beckeringh; D Leupold; S K Wadman
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

3.  Early nerve ending rescue from oxidative damage and energy failure by L: -carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities.

Authors:  Diana Elinos-Calderón; Yolanda Robledo-Arratia; Verónica Pérez-De La Cruz; José Pedraza-Chaverrí; Syed F Ali; Abel Santamaría
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

Review 4.  L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.

Authors:  Gustavo C Ferreira; Mary C McKenna
Journal:  Neurochem Res       Date:  2017-05-16       Impact factor: 3.996

Review 5.  The Impact of Carnitine on Dietary Fiber and Gut Bacteria Metabolism and Their Mutual Interaction in Monogastrics.

Authors:  Abdallah Ghonimy; Dong Ming Zhang; Mohammed Hamdy Farouk; Qiuju Wang
Journal:  Int J Mol Sci       Date:  2018-03-28       Impact factor: 5.923

6.  Inhibition of oxidative metabolism by propionic acid and its reversal by carnitine in isolated rat hepatocytes.

Authors:  E P Brass; P V Fennessey; L V Miller
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

Review 7.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

8.  L-carnitine in inborn errors of metabolism: what is the evidence?

Authors:  J H Walter
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 9.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

10.  Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids.

Authors:  E P Brass; R A Beyerinck
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.